I
Consumer Discretionary

Inspire Veterinary Partners, Inc.

IVP
Since 2020

Headquarters:

VA, United States

Exchange:

NASDAQ

Industry:

Personal Services

Number of Employees:

156.00

Current Fiscal Year:

2024

Market Cap:

44.92M

Price per Share:

$1.53

Quarterly Dividend per Share:

Year-to-date Performance:
-70.3201%
Dividend Yield:
%
Price-to-book Ratio:
14.83
Trailing P/E Ratio:
N/A

Price History

Latest Prices

DateOpenHighLowClose
2025-04-301.541.571.421.53
2025-04-291.521.591.46561.525
2025-04-281.621.621.51.52
2025-04-251.511.63991.51.63
2025-04-241.51.571.451.541

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds, including equine care. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. It also offers surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. The company was incorporated in 2020 and is based in Virginia Beach, Virginia.

Financial Performance

2024 Revenue:17.05M

Detailed view of quarterly revenue

2024 Net Income:-14.44M

Detailed view of quarterly net income

2024 Free Cash Flow:-10.31M

Overview of free cash flow for the quarter

Annual Revenue Comparison

Compares total annual revenues

Similar Companies

Health Care
PETQ
PetIQ, Inc.
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. As of October 25, 2024, PetIQ, Inc. was taken private.
919.17M
Market Cap
*Data based on the last 12 months.